Tao Xu

Tao Xu

Auto-generated profile, based on publicly available information

Tao Xu

The University of Texas Health Science Center at Houston, Houston, TX , USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
SFShenying Fang
Shenying Fang
TXTao Xu
Tao Xu
MXMomiao Xiong
Momiao Xiong
XZXinke Zhou
Xinke Zhou
YWYuling Wang
Yuling Wang
JLJeffrey E Lee
Jeffrey E Lee

22 May 2022 in Applied Mathematics and Computation
Verified
Journal Article
Closed access
XQXing Qiu
Xing Qiu
TXTao Xu
Tao Xu
BSBabak Soltanalizadeh
Babak Soltanalizadeh
HWHulin Wu
Hulin Wu

29 September 2020 in medRxiv
Verified
Preprint
Open access
PDF file
ZLZhouxuan Li
Zhouxuan Li
TXTao Xu
Tao Xu
KZKai Zhang
Kai Zhang
HDHongwen Deng
Hongwen Deng
EBEric Boerwinkle
Eric Boerwinkle
MXMomiao Xiong
Momiao Xiong
As of August 27, 2020, the number of cumulative cases of COVID-19 in the US exceeded 5,863,363 and included 180,595 deaths, thus causing a serious public health crisis. Curbing the spread of Covid-19 is still urgently needed. Given the lack of potential vaccines and effective medications, non-pharmaceutical interventions are the major option to curtail the spread of COVID-19. An accurate estimate of the potential impact of different non-pharmaceutical measures on containing, and identify risk factors influencing the spread of COVID-19 is crucial for planning the most effective interventions to curb the spread of COVID-19 and to reduce the deaths. Additive model-based bivariate causal discovery for scalar factors and multivariate Granger causality tests for time series factors are applied to the surveillance data of lab-confirmed Covid-19 cases in the US, University of Maryland Data (UMD) data, and Google mobility data from March 5, 2020 to August 25, 2020 in order to evaluate the contributions of social-biological factors, economics, the Google mobility indexes, and the rate of the virus test to the number of the new cases and number of deaths from COVID-19. We found that active cases/1000 people, workplaces, tests done/1000 people, imported COVID-19 cases, unemployment rate and unemployment claims/1000 people, mobility trends for places of residence (residential), retail and test capacity were the most significant risk factor for the new cases of COVID-19 in 23, 7, 6, 5, 4, 2, 1 and 1 states, respectively, and that active cases/1000 people, workplaces, residential, unemployment rate, imported COVID cases, unemployment claims/1000 people, transit stations, mobility trends (transit), tests done/1000 people, grocery, testing capacity, retail, percentage of change in consumption, percentage of working from home were the most significant risk factor for the deaths of COVID-19 in 17, 10, 4, 4, 3, 2, 2, 2, 1, 1, 1, 1 states, respectively. We observed that no metrics showed significant evidence in mitigating the COVID-19 epidemic in FL and only a few metrics showed evidence in reducing the number of new cases of COVID-19 in AZ, NY and TX. Our results showed that the majority of non-pharmaceutical interventions had a large effect on slowing the transmission and reducing deaths, and that health interventions were still needed to contain COVID-19.